| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 10/10/2001 | EP1140956A1 Ligands and complexes for enantioselective hydrogenation |
| 10/10/2001 | EP1140846A1 Aspartic protease inhibitors |
| 10/10/2001 | EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 10/10/2001 | EP1140833A1 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity |
| 10/10/2001 | EP1140829A1 Contrast media for angiography |
| 10/10/2001 | EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea |
| 10/10/2001 | EP1140821A1 Lactams |
| 10/10/2001 | EP1140820A1 New amidino derivatives and their use as thrombin inhibitors |
| 10/10/2001 | EP1140819A1 Alfa-sulfenimino acid derivatives |
| 10/10/2001 | EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/10/2001 | EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 10/10/2001 | EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 10/10/2001 | EP1140800A1 Multifunctional imine-esters as novel crosslinkers for surface coatings |
| 10/10/2001 | EP1140791A2 Selective cpla 2 inhibitors |
| 10/10/2001 | EP1140087A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 10/10/2001 | EP1140086A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 10/10/2001 | EP1140085A1 Azabicycloalkanes as ccr5 modulators |
| 10/10/2001 | EP1140046A1 Use of a mek inhibitor for preventing transplant rejection |
| 10/10/2001 | EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 10/10/2001 | EP0791581B1 Uch15 compounds |
| 10/10/2001 | CN1316992A Process for preparation of zofenopril calcium salt |
| 10/10/2001 | CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative |
| 10/10/2001 | CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines |
| 10/09/2001 | US6300504 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates |
| 10/09/2001 | US6300502 Multi-armed chromophores with very large two-photon absorption cross-sections |
| 10/09/2001 | US6300456 Compounds with electron donor and electron acceptor functionality |
| 10/09/2001 | US6300366 Aminopyrroline compounds |
| 10/09/2001 | US6300341 2-substituted heterocyclic sulfonamides |
| 10/09/2001 | CA2016501C Substituted pyrrole compounds and their applications in pharmacy |
| 10/04/2001 | WO2001072960A2 Il-8 receptor antagonists |
| 10/04/2001 | WO2001072728A2 Novel piperazine derivatives |
| 10/04/2001 | WO2001072706A1 Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 10/04/2001 | WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 10/04/2001 | WO2001072701A1 Ceramide derivatives and method of use |
| 10/04/2001 | WO2001072687A1 Diphenyl ether compounds useful in therapy |
| 10/04/2001 | WO2001072685A2 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | WO2001072673A1 Anthracene derivatives and organic electroluminescent devices made by using the same |
| 10/04/2001 | WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 10/04/2001 | WO2001021577A3 Melanin concentrating hormone antagonist |
| 10/04/2001 | US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma |
| 10/04/2001 | EP1138681A1 A process for the preparation of acyl heteroaromatic compounds from heteroaromatic compounds by metal ion exchanged clays |
| 10/04/2001 | EP1138672A1 Process for the preparation of 3-amino-pyrrolidine derivatives |
| 10/04/2001 | EP1137647A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137635A1 N-substituted 2-cyanopyrrolidines |
| 10/04/2001 | EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137412A2 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof |
| 10/04/2001 | EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 10/04/2001 | EP0757673B1 Heterocyclylbenzonitriles |
| 10/04/2001 | EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2404439A1 Diphenyl ether compounds useful in therapy |
| 10/04/2001 | CA2403814A1 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2402769A1 Ceramide derivatives and method of use |
| 10/04/2001 | CA2401242A1 Pharmaceutically active pyrrolidine derivatives |
| 10/03/2001 | CN1315873A Prevention/remedies for multiple organ failure |
| 10/03/2001 | CN1315860A Method for treating hot flashes in humans |
| 10/03/2001 | CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates |
| 10/03/2001 | CN1072217C Process for producing 2-substituted-3,4-condensed heterocyclic benzoic acid |
| 10/03/2001 | CN1072208C Snopori crystal preparation and quality testing |
| 10/02/2001 | US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene |
| 10/02/2001 | US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them |
| 10/02/2001 | US6297283 Excellent inhibitory effect on the production of an ige antibody and are hence useful as antiallergic agents |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297233 Lactam inhibitors of FXa and method |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |
| 10/02/2001 | CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof |
| 10/02/2001 | CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070685A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | WO2001070684A2 Peptidomimetic ligands for cellular receptors and ion channels |
| 09/27/2001 | WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001017972A3 Novel herbicides |
| 09/27/2001 | WO2001014576B1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 09/27/2001 | US20010025109 Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use |
| 09/27/2001 | US20010025105 Anticancer agent; Alzheimer's therapy |
| 09/27/2001 | US20010024749 Surface modified carbonaceous materials |
| 09/27/2001 | CA2723664A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | CA2404236A1 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | CA2403778A1 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2401728A1 Difluorobutyric acid metalloprotease inhibitors |
| 09/27/2001 | CA2391316A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/26/2001 | EP1136466A2 Process for racemising N-acyl-amino acids with transition metal catalysts |
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135371A1 Beta-alanine derivatives as alpha 4 integrin inhibitors |
| 09/26/2001 | EP1135370A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 09/26/2001 | EP1135122A2 Use of amtolmetin guacyl as an antiinflammatory drug |
| 09/26/2001 | CN1314883A Amino acid derivatives and drug containing the same as the active ingredient |
| 09/26/2001 | CN1314881A Imidamide derivatives |
| 09/26/2001 | CN1071746C Amidine derivatives with nitric oxide synthetase activities |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294574 Compounds and methods for the treatment of inflammatory and immune disorders |
| 09/25/2001 | US6294573 Reverse hydroxamate inhibitors of matrix metalloproteinases |
| 09/25/2001 | US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |